Intel's Advanced Packaging Push Reinforces Foundry Focus but Lacks Financial Proof

What happened

Intel is stepping up its advanced chip packaging efforts to challenge TSMC's dominance in AI hardware, targeting efficient processor-memory links. This aligns with the DeepValue report's identification of advanced packaging and trusted foundry as earlier monetization paths before large external wafer volumes scale. However, current financials show Intel Foundry external revenue remains small at $293 million in Q2 2026 while operating losses stay steep at $2.1 billion, indicating packaging efforts are nascent and not yet offsetting losses. The news does not alter the WAIT thesis, which hinges on proving external foundry demand through milestones like the October 2026 14A PDK and significant customer announcements. Investors should treat this as a confirmation of Intel's packaging focus but remain skeptical until packaging revenue becomes visible in financial results and contributes to narrowing foundry losses.

Implication

For the next few quarters, watch whether Intel's advanced packaging efforts translate into disclosed external revenue above the current $293 million and whether foundry losses begin to narrow. The market has already rewarded Intel for AI-related recovery, but packaging wins are still in early stages and may not justify further multiple expansion without financial proof. The stock's valuation at $97.7 with EV/EBITDA of 37 leaves little room for execution missteps; any delay in packaging ramp or 14A customer announcements could trigger downside. Investors should monitor Q3 2026 results for any commentary on packaging customer commitments and EMIB-T backlog conversion, as those are indicators of future revenue. Until then, maintain a cautious stance, with attractive entry near $82 and trim above $115 per the report's framework.

Thesis delta

No thesis change from this news. The report already emphasized advanced packaging as an earlier monetization path, and this article confirms Intel's focus. However, the fundamental evidence required—scaling external foundry revenue and reducing losses—remains outstanding.